Evoke Pharma Revenue, Profits - EVOK Quarterly Income Statement

Add to My Stocks
$2.07 $0.09 (4.55%) EVOK stock closing price Mar 21, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Evoke Pharma stock price alone is not sufficient. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2017 Q3 impacts the EVOK stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Evoke Pharma assets and Evoke Pharma free cash flow, Evoke Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 Q3 is $-5.24M and the 2017 Q3 revenue is $-.

View and download details of revenue and profits for Evoke Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Evoke Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)---------
Evoke Pharma Gross Profit
Research & Development Expense2.71M2.01M-1.52M1.33M2.09M2.01M1.73M1.83M
Selling General & Admin Expense--1.2M---1.13M--
Income Before Depreciation Depletion Amortization-3.7M-2.88M-1.98M-2.34M-2.16M-2.89M-3.15M-2.56M-2.65M
Depreciation Depletion Amortization---------
Non Operating Income-1.54M1.26M-3.07M--0.73M-0.07M-0.07M-0.3M-
Interest Expense--------0.21M-
Evoke Pharma Pretax Income
Provision for Income Taxes---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-5.24M-1.63M-5.05M-1.53M-3.03M-2.97M-3.23M-2.62M-2.74M
Extraordinary Items & Discontinued Operations---------
Evoke Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS15.35M15.42M13.53M12.31M10.62M7.22M7.17M7.12M6.5M
Average Shares used to compute Basic EPS15.35M15.34M13.53M12.31M10.62M7.22M7.17M7.12M6.5M
Income Before Nonrecurring Items-3.7M-2.89M-1.98M-2.32M-2.49M-2.97M-3.23M-2.62M-2.74M
Income from Nonrecurring Items-1.54M1.26M-3.07M--0.53M----
Evoke Pharma Earnings Per Share Basic Net
Evoke Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.24-0.27-0.14-0.18-0.24-0.41-0.45-0.37-0.42
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Evoke Pharma stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Evoke Pharma revenue chart, implies that the company is growing. It has not been the case with Evoke Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. EVOK stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the EVOK income statement, one can check the Evoke Pharma historical stock prices to check how the price has moved with time.

Evoke Pharma Income Statement - Key Financial Ratios